[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577989":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":28,"responsibleParty":72,"collaborators":10,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":10,"enrollmentInfo":84,"targetDuration":87,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":92,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"RenovoRx","INDUSTRY",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Patients receiving Intra-Arterial treatment with RenovoCath",null,[12],"Device: RenovoCath®",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","RenovoCath®","Intra-arterial catheter delivery of chemotherapy agents for the collection of real-world data.",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Leesa M Gentry","CONTACT","650-284-4433","lgentry@renovorx.com",{"name":26,"role":22,"phone":23,"phoneExt":10,"email":27},"Nicolette G Keller","nkeller@renovorx.com",[29,46,59],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Baptist Health South Florida","RECRUITING","Coral Gables","Florida","33143","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-80.26838,25.72149,{"lat":41,"lon":40},[44],{"name":45,"role":22,"phone":10,"phoneExt":10,"email":10},"Dr. Gandhi",{"facility":47,"status":31,"city":48,"state":49,"zip":50,"country":35,"countryCode":36,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"University of Pennsylvania Medical Center","Pittsburgh","Pennsylvania","15213",{"type":38,"coordinates":52},[53,54],-79.99589,40.44062,{"lat":54,"lon":53},[57],{"name":58,"role":22,"phone":10,"phoneExt":10,"email":10},"Dr. Novelli",{"facility":60,"status":31,"city":61,"state":62,"zip":63,"country":35,"countryCode":36,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"The University of Vermont Medical Center","Burlington","Vermont","05401",{"type":38,"coordinates":65},[66,67],-73.21207,44.47588,{"lat":67,"lon":66},[70],{"name":71,"role":22,"phone":10,"phoneExt":10,"email":10},"Dr. O'Neill",{"type":73,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100577989","pumarx-registry-trial-100577989",false,"NCT06805461","PumaRx Registry Trial","A Multi-Center, Observational, Post-Marketing, Registry Study Following Patients With Solid Tumors Treated With Therapeutic Agents Via Localized Intra-Arterial Delivery Using the RenovoCath® Catheter","PumaRx","Eligibility Criteria:\n\n1. Male and female patients who have been diagnosed with solid tumor cancers and are at least 18 years of age at the time of the first IA procedure\n2. Patients willing to provide informed consent and HIPAA release for use of their relevant medical records","ALL","18 Years",{"count":85,"type":86},1000,"ESTIMATED","36 Months","OBSERVATIONAL","This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.",[91],"Solid Tumors",[93],"Intra-Arterial Catheter","2026-03-25",{"date":96,"type":97},"2026-03-30","ACTUAL",{"date":99,"type":97},"2025-08-01",{"date":101,"type":86},"2029-09-03",{"name":5,"class":6},3]